Cue Biopharma, Inc.
General ticker "CUE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $45.0M (TTM average)
Cue Biopharma, Inc. does not follow the US Stock Market performance with the rate: -16.6%.
Estimated limits based on current volatility of 17.2%: low 0.53$, high 0.75$
Factors to consider:
- Total employees count: 53 (+3.9%) as of 2023
- Top business risk factors: Lack of profitability, High R&D costs, Regulatory and compliance, Third-party risks, Need for additional capital
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.31$, 1.00$]
- 2026-12-31 to 2027-12-31 estimated range: [0.41$, 1.21$]
Financial Metrics affecting the CUE estimates:
- Positive: with PPE of -0.9 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -77.40 <= 0.07
- Positive: Investing cash flow per share per price, % of 0.27 > -0.65
- Positive: 42.60 < Shareholder equity ratio, % of 62.62 <= 64.25
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Interest expense per share per price, % of 1.27 <= 3.29
Short-term CUE quotes
Long-term CUE plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $5.49MM | $9.29MM | $27.47MM |
| Operating Expenses | $57.64MM | $50.79MM | $54.02MM |
| Operating Income | $-52.15MM | $-41.50MM | $-26.55MM |
| Non-Operating Income | $1.42MM | $0.83MM | $0.45MM |
| Interest Expense | $1.25MM | $0.80MM | $0.36MM |
| R&D Expense | $40.80MM | $36.30MM | $37.74MM |
| Income(Loss) | $-50.73MM | $-40.67MM | $-26.10MM |
| Taxes | $0.00MM | $0.00MM | $0.50MM |
| Profit(Loss)* | $-50.73MM | $-40.67MM | $-26.60MM |
| Stockholders Equity | $37.09MM | $17.50MM | $26.43MM |
| Assets | $61.53MM | $32.19MM | $42.21MM |
| Operating Cash Flow | $-39.96MM | $-36.33MM | $-21.69MM |
| Capital expenditure | $0.00MM | $0.07MM | $0.18MM |
| Investing Cash Flow | $25.00MM | $0.03MM | $0.07MM |
| Financing Cash Flow | $11.86MM | $10.24MM | $26.29MM |
| Earnings Per Share** | $-1.11 | $-0.72 | $-0.28 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.